Negative Symptoms in Schizophrenia
14
4
4
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 14 trials
100.0%
+13.5% vs benchmark
14%
2 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (14)
ENGAGE: Virtual Reality-based Psychotherapy for Negative Symptoms in Schizophrenia
An Extension Study of a Second Course of a Digital Therapeutic for the Treatment of Experiential Negative Symptoms of Schizophrenia
tACS to Improve Negative Symptoms & Cognition in Long-term Hospitalized Schizophrenia Patients.
Online HD-tDCS Over the Left DLPFC During a Working Memory Task for Treating Negative Symptoms of Schizophrenia
40 Hz Visual Stimulation as an Intervention in Schizophrenia
A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Co-Administration of Roluperidone and Olanzapine in Adult Subjects With Moderate to Severe Negative Symptoms of Schizophrenia
NST-SPARK: Preliminary Study of an Augmented Reality (AR) App Delivering Recovery-Oriented Cognitive Therapy for Negative Symptoms in Schizophrenia
Treatment of Negative Symptoms of Schizophrenia by rTMS
Validation of the Lithuanian Version of the BNSS, CDSS, and the SCoRS
Metacognitive Training for Negative Symptoms
Optimal rTMS for Cognitive Deficits and Negative Symptoms in Schizophrenia
Dance and Movement Therapy in Patients With Schizophrenia
Effectiveness of Behavioral Activation Treatment for Schizophrenia
A Study on the Efficacy of Agomelatine Combined With Antipsychotics to Treat Negative Symptoms in Schizophrenia